Back to Journals » Cancer Management and Research » Volume 10

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil

Total article views   Abstract views HTML views PDF downloads Totals
3,745 Dovepress* 3,045 312+ 446 3,357
PubMed Central* 0 388 115 388
Totals 3,045 700 561 3,745
*Since 15 August 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 0 3 4

View citations on PubMed Central and Google Scholar